NeuroBo Pharmaceuticals, Inc. Appoints Pharmaceutical Industry Executive, Mark A. Glickman, to its Board of Directors

/PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company on a quest to transform cardiometabolic diseases, today...

Related Keywords

Boston ,Massachusetts ,United States ,Andrewi Koven ,Marka Glickman ,Michael Miller ,Abbott Laboratories ,Aralez Pharmaceuticals Inc ,Donga St Co ,York University Stern School Of Business ,Therapeuticsmd Inc ,Neurobo Pharmaceuticals ,International Management ,Kos Pharmaceuticals ,Marketing For Auxilium Pharmaceuticals Endo ,University Of New York Oswego ,Esperion Therapeutics Inc ,Rx Communications Group ,Devices For Otsuka America Pharmaceuticals Inc ,Prnewswire Neurobo Pharmaceuticals Inc ,Neurobo Pharmaceuticals Inc ,Nasdaq ,Neurobo Board ,G Protein Coupled Receptor ,Investigational New Drug ,Co Chief Executive ,Mayne Therapeutics ,Chief Business Officer ,Chief Commercial Officer ,Esperion Therapeutics ,Executive Vice President ,Auxilium Pharmaceuticals ,Endo Pharmaceuticals ,Senior Vice President ,Vice President ,Medical Devices ,Otsuka America Pharmaceuticals Inc ,Regional Sales Director ,Political Science ,State University ,New York Oswego ,Business Administration ,New York University ,Stern School ,Non Alcoholic Steatohepatitis ,Private Securities Litigation Reform Act ,Nc ,